I joined AstraZeneca in 2013, as a Senior Statistician in Discovery Sciences. Before becoming a Statistical Team Leader in Early Clinical Development, I supported project teams as statistical lead across multiple disease areas. In 2020, I stepped into the role of 早期呼吸科主任 & 免疫学的统计数据, managing a global team of statisticians in the design, 规划, analysis and reporting of early clinical trials. I bring a combination of experience from multiple therapy areas and stages of drug development, and a wide operational expertise. I have been co-leading innovation workstreams such as the Seamless Ph2/3 and Early Phase Endpoints, represented early statistics at governance interactions and contributed as a Global Product Statistician and Biometrics Team Leader across 澳门第一赌城在线娱乐. After an MSc in Engineering Physics, I directed my PhD research towards stochastic modeling and analysis of the developing mouse embryo. Continuing the stochastic modeling track, I held a postdoc at Fraunhofer Chalmers Centre for Industrial Mathematics focusing on PK/PD modelling of non-esterified fatty acids in pre-clinical models.
My work connects directly to AstraZeneca’s mission of being a patient-centric BioPharmaceutical company in the way that we as statisticians always have novel tech in the forefront of what we're doing. We are trying to find ways of doing our clinical trials more efficiently and better suited to patients’ needs, by applying statistical learning, AI and other data science tools.
2021
电流的作用
目前角色
2017 Principal Statistician Early Clinical Development
2011 PhD in Mathematical Statistics at Chalmers University in 哥德堡
Veeva ID: Z4-46883
Date of preparation: July 2022